Agata Bielecka‐Dąbrowa

4.2k total citations · 1 hit paper
117 papers, 2.7k citations indexed

About

Agata Bielecka‐Dąbrowa is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Agata Bielecka‐Dąbrowa has authored 117 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Cardiology and Cardiovascular Medicine, 25 papers in Molecular Biology and 23 papers in Surgery. Recurrent topics in Agata Bielecka‐Dąbrowa's work include Heart Failure Treatment and Management (19 papers), Lipoproteins and Cardiovascular Health (14 papers) and Cardiovascular Function and Risk Factors (13 papers). Agata Bielecka‐Dąbrowa is often cited by papers focused on Heart Failure Treatment and Management (19 papers), Lipoproteins and Cardiovascular Health (14 papers) and Cardiovascular Function and Risk Factors (13 papers). Agata Bielecka‐Dąbrowa collaborates with scholars based in Poland, Germany and United States. Agata Bielecka‐Dąbrowa's co-authors include Maciej Banach, Jacek Rysz, Dimitri P. Mikhailidis, Stephan von Haehling, Susanne Häußler, Wilbert S. Aronow, Denitsa Eckweiler, Vítor A. P. Martins dos Santos, Marta Michalska and Marek Maciejewski and has published in prestigious journals such as Nucleic Acids Research, Circulation and Nature Communications.

In The Last Decade

Agata Bielecka‐Dąbrowa

108 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis

2023 90 citations Maciej Banach, Joanna Lewek et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Agata Bielecka‐Dąbrowa Poland	31	990	777	360	285	269	117	2.7k
Hyun‐Jung Lee South Korea	34	835 0.8×	1.2k 1.5×	397 1.1×	92 0.3×	387 1.4×	180	3.5k
Han Wang China	27	1.0k 1.0×	214 0.3×	358 1.0×	162 0.6×	320 1.2×	178	2.8k
Rakesh K. Singh United States	27	943 1.0×	507 0.7×	697 1.9×	88 0.3×	246 0.9×	104	3.2k
Huang‐Ping Yu Taiwan	32	728 0.7×	231 0.3×	569 1.6×	180 0.6×	282 1.0×	146	3.0k
Hiroyuki Takase Japan	28	529 0.5×	1.5k 1.9×	312 0.9×	159 0.6×	775 2.9×	119	2.9k
Liffert Vogt Netherlands	31	606 0.6×	916 1.2×	450 1.3×	170 0.6×	391 1.5×	180	3.6k
Andrew J. King United States	26	692 0.7×	323 0.4×	384 1.1×	128 0.4×	462 1.7×	79	2.7k
Wei He China	29	581 0.6×	187 0.2×	198 0.6×	197 0.7×	313 1.2×	168	2.7k
Bingyuan Wang China	28	877 0.9×	477 0.6×	583 1.6×	182 0.6×	475 1.8×	124	3.2k

Countries citing papers authored by Agata Bielecka‐Dąbrowa

Since Specialization

Citations

This map shows the geographic impact of Agata Bielecka‐Dąbrowa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agata Bielecka‐Dąbrowa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agata Bielecka‐Dąbrowa more than expected).

Fields of papers citing papers by Agata Bielecka‐Dąbrowa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agata Bielecka‐Dąbrowa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agata Bielecka‐Dąbrowa. The network helps show where Agata Bielecka‐Dąbrowa may publish in the future.

Co-authorship network of co-authors of Agata Bielecka‐Dąbrowa

This figure shows the co-authorship network connecting the top 25 collaborators of Agata Bielecka‐Dąbrowa. A scholar is included among the top collaborators of Agata Bielecka‐Dąbrowa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agata Bielecka‐Dąbrowa. Agata Bielecka‐Dąbrowa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Banach, Maciej, Stanisław Surma, Agata Bielecka‐Dąbrowa, et al.. (2025). Rosuvastatin-Based Combination Treatment with Acetylsalicylic Acid or Ezetimibe in the Management of Patients at High and Very High Cardiovascular Risk. Expert Opinion Paper of the Polish Lipid Association 2025.. Archives of Medical Science. 21(1). 1–15. 2 indexed citations

Osbelt, Lisa, Till Robin Lesker, Agata Bielecka‐Dąbrowa, et al.. (2025). Suppression of gut colonization by multidrug-resistant Escherichia coli clinical isolates through cooperative niche exclusion. Nature Communications. 16(1). 5426–5426. 2 indexed citations

Sosnowska, Bożena, Joanna Lewek, Agata Bielecka‐Dąbrowa, et al.. (2024). The prevalence, patients' characteristics, and hyper-Lp(a)-emia risk factors in the Polish population. The first results from the PMMHRI-Lp(a) Registry. Progress in Cardiovascular Diseases. 86. 54–61. 8 indexed citations

Lewek, Joanna, Agata Bielecka‐Dąbrowa, Peter P. Tóth, & Maciej Banach. (2024). Dyslipidaemia management in pregnant patients: a 2024 update. European Heart Journal Open. 4(3). oeae032–oeae032. 20 indexed citations

Kupczyńska, Karolina, et al.. (2024). The Role of Gut Microbiota and Its Metabolites in Patients with Heart Failure. Biomedicines. 12(4). 894–894. 13 indexed citations

Bielecka‐Dąbrowa, Agata, et al.. (2024). The Effect of Sex on the Risk of Long-COVID and Cardiovascular Complications in Healthy Patients without Comorbidities: Data from a Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study. Journal of Clinical Medicine. 13(6). 1559–1559. 3 indexed citations

Lewek, Joanna, et al.. (2024). Lipoprotein(a) and Other Risk Factors in Dyslipidemic Patients with and without Heart Failure.. Archives of Medical Science. 20(5). 1705–1709.

Moszura, Tomasz, et al.. (2023). Dorosła z Tetralogią Fallota, anomalią odejścia tętnicy wieńcowej, niescaleniem lewej komory, ubytkiem w przegrodzie międzyprzedsionkowej i nawracającym zwężeniem w drodze odpływu prawej komory. Folia Cardiologica. 18(1). 38–41.

Bielecka‐Dąbrowa, Agata, et al.. (2023). The Importance of Optimal Hydration in Patients with Heart Failure—Not Always Too Much Fluid. Biomedicines. 11(10). 2684–2684. 6 indexed citations

10.

Bielecka‐Dąbrowa, Agata, Maciej Banach, Arrigo F.G. Cicero, et al.. (2023). The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper.. Archives of Medical Science. 7 indexed citations

11.

Lewek, Joanna, Jacek Niedziela, Piotr Desperak, et al.. (2023). Intensive Statin Therapy Versus Upfront Combination Therapy of Statin and Ezetimibe in Patients With Acute Coronary Syndrome: A Propensity Score Matching Analysis Based on the PL‐ACS Data. Journal of the American Heart Association. 12(18). e030414–e030414. 25 indexed citations

12.

Banach, Maciej, et al.. (2023). The Role of Multidisciplinary Approaches in the Treatment of Patients with Heart Failure and Coagulopathy of COVID-19. Journal of Cardiovascular Development and Disease. 10(6). 245–245. 1 indexed citations

13.

Banach, Maciej, et al.. (2021). The Relationship of Dehydration and Body Mass Index With the Occurrence of Atrial Fibrillation in Heart Failure Patients. Frontiers in Cardiovascular Medicine. 8. 668653–668653. 4 indexed citations

14.

Sakowicz, Agata, et al.. (2019). Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology. Disease Markers. 2019. 1–10. 6 indexed citations

15.

Binder, Sebastian C., Denitsa Eckweiler, Agata Bielecka‐Dąbrowa, et al.. (2016). Functional modules of sigma factor regulons guarantee adaptability and evolvability. Scientific Reports. 6(1). 22212–22212. 14 indexed citations

16.

Acuña, José Manuel Borrero‐de, Agata Bielecka‐Dąbrowa, Susanne Häußler, et al.. (2014). Production of medium chain length polyhydroxyalkanoate in metabolic flux optimized Pseudomonas putida. Microbial Cell Factories. 13(1). 88–88. 82 indexed citations

17.

Gluba-Brzózka, Anna, Agata Bielecka‐Dąbrowa, Nathan D. Wong, et al.. (2012). An update on biomarkers of heart failure in hypertensive patients. Journal of Hypertension. 30(9). 1681–1689. 44 indexed citations

18.

Maciejewski, Marek, et al.. (2011). Redo surgery risk in patients with cardiac prosthetic valve dysfunction. Archives of Medical Science. 2(2). 271–277. 12 indexed citations

19.

Bobadilla-Fazzini, Roberto A., et al.. (2009). Bacterial consortium proteomics under 4‐chlorosalicylate carbon‐limiting conditions. PROTEOMICS. 9(8). 2273–2285. 14 indexed citations

20.

Bielecka‐Dąbrowa, Agata. (2007). Urządzenia wspomagające pracę komór: leczenie pomostowe do momentu uzyskania ponownej wydolności komory lub do czasu przeszczepu oraz leczenie docelowe. Folia Cardiologica. 2(2). 54–64.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact